US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 16, 2019 (7 years ago)

Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

What was recalled

Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Recalling firm
Deva Holding AS - Cerkezkoy Subesi
NDC code
67877-539-07
Origin
N/A, Turkey
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1510-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Temozolomide recalls

See all